Capricor Gets Complete Response For DMD Cell Therapy: Unconvincing Data Or New Attitude At FDA?

 
• By Joseph Haas
  
DMD
Capricor hopes an ongoing Phase III study will provide data needed to resolve a CRL • Source: Shutterstock

More from Complete Response Letters

More from Product Reviews